The Patent Finder

FC Containing Polypeptides with Altered Glycosylation and Reduced Effector Function

Genzyme Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/EP2012/003819, filed Sep 12, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,836,813FC Containing Polypeptides with Altered Glycosylation and Reduced Effector Function
In force
 · Medium confidence
Genzyme CorporationIn force
Medium confidence
US 9,790,268FC Containing Polypeptides with Altered Glycosylation and Reduced Effector Function
In force
 · Medium confidence
Genzyme CorporationIn force
Medium confidence
US 12,612,458Anti-Alphabetatcr Antibody
In force
 · Medium confidence
Genzyme CorporationIn force
Medium confidence
US 11,186,638Anti-Alphabetatcr Antibody
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 12,503,498FC Containing Polypeptides with Altered Glycosylation and Reduced Effector Function
In force
 · Medium confidence
Genzyme CorporationIn force
Medium confidence
Application 19/324,708Anti-Alphabetatcr Antibody
Pending
Not granted
Genzyme CorporationPendingNot granted
Application 19/387,958FC Containing Polypeptides with Altered Glycosylation and Reduced Effector Function
Pending
Not granted
Genzyme CorporationPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Genzyme Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited